GMR Solutions GMRS
GMR Solutions reports Q3 2026 results
Item 2.02 Reports results
- Form
- 8-K
- Filed
- Importance
- Major
- Accession
- 0001104659-26-124559
- Net revenue of $1,595.6 million, up 5.9% from $1,506.9 million
- Net income of $135.6 million, up 81.7% from $74.6 million
- Adjusted EBITDA of $356.6 million, up 4.2% from $342.1 million
- Updated full year 2026 net revenue guidance between $5.9 billion and $6.05 billion
Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.
The reading, claim by claim
- Under Item 2.02, it said it issued a press release that day announcing results for the three and nine months ended September 30, 2026, furnished as Exhibit 99.1.
- Item 2.02 states the information, including Exhibit 99.1, is furnished and not deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934.
- Item 9.01 lists the press release dated November 9, 2026 as Exhibit 99.1, along with the cover page interactive data file as Exhibit 104.
- The press release reports third quarter net revenue of $1,595.6 million, up 5.9% from $1,506.9 million in the third quarter of 2025.
- Net income was $135.6 million, up 81.7% from $74.6 million.
- Adjusted EBITDA, a non-GAAP measure, was $356.6 million, up 4.2%.
- The release says liquidity was approximately $999.3 million as of September 30, 2026, made up of $298.0 million of cash and cash equivalents and approximately $701.3 million of available ABL Facility borrowing capacity.
- It also describes the September 17, 2026 repricing of the senior secured term loan due 2032, which included a $200.0 million repayment and a 50 basis point reduction in the interest rate.
8 of 8 claims matched the filing text.
For perspective, checked against its own source
From the 10-Q for the quarter ended June 30, 2026
- For context, in its 10-Q for the quarter ended June 30, 2026, GMR Solutions Inc. reported revenue of $1.5 billion, net income of -$28.3 million, and revenue growth of +3.3% from a year earlier.
From the filing
Item 2.02 Results of Operations and Financial Condition.
On November 9, 2026, GMR Solutions Inc. (the "Company") issued a press release announcing its financial results for the three and nine months ended September 30, 2026.1 1A copy of the Company's press release is furnished as Exhibit 99.11 to this Current Report on Form 8-K.
The information contained in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 19342 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
Exhibit No.
Description of Exhibit
Press release of GMR Solutions Inc. dated November 9, 20263
Cover Page Interactive Data File3 – The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
GMR SOLUTIONS INC.
Date: November 9, 2026
By:
/s/ Brian Tierney
Name:
Brian Tierney
Title:
Executive Vice President and Chief Financial Officer
GMR Solutions Inc. Reports Financial Results for the Three and Nine Months Ended September 30, 2026 and Updated Full Year 2026 Guidance
LEWISVILLE, Texas (November 9, 2026) — GMR Solutions Inc. ("GMR" or the "Company") (NYSE: GMRS), the nation's largest provider of emergency medical services ("EMS"), today announced financial results for the three and nine months ended September 30, 2026, and updated its full year 2026 financial guidance.
"The third quarter showcased the resiliency that is inherent in GMR's scale, national footprint, and integrated model," said Nick Loporcaro, Chairman and Chief Executive Officer. "Our ability to serve patients across a broad range of operations and geographies helped us navigate weather-related constraints and other external pressures while continuing to grow our core emergent services. Combined with the momentum we are seeing in Nurse Navigation and new market growth, these results reinforce our confidence in the strength of our platform and opportunities ahead."
"We delivered strong financial performance in the third quarter, with revenue increasing 5.9% to $1,595.6 million, and net income increasing 81.7% to $135.6 million, despite weather-related pressure on flight activity, higher fuel and other inflationary costs, and the anticipated shift in payor mix," said Brian Tierney, Chief Financial Officer. "Growth in our core emergent services, continued improvement in revenue per transport and disciplined cost management helped us absorb these headwinds while continuing to invest in the business and strengthen our financial position."
Third Quarter 2026 Financial Highlights
● Reduced leverage and strengthened the Company's balance sheet through a series of strategic capital transactions, including the repricing of its senior secured term loan due 2032 on September 17, 2026, which included the repayment of $200.0 million of senior secured term loan borrowings and a reduction to the applicable interest rate by 50 basis points8.
(1) Adjusted EBITDA is a non-GAAP financial measure. Please see "Non-GAAP Financial Measures" at the end of this press release for a reconciliation of Adjusted EBITDA to net income, the most directly comparable financial measure prepared in accordance with generally accepted accounting principles in the United States ("GAAP").
Key Financials
Three Months Ended
Nine Months Ended
September 30,
September 30,
2026
2025
%
2026
2025
%
| Net revenue | $1,595,555 | $1,506,868 | 5.9% | $4,543,417 | $4,316,286 | 5.3% |
|---|---|---|---|---|---|---|
| Net income | $135,555 | $74,599 | 81.7% | $213,613 | $193,384 | 10.5% |
| Adjusted EBITDA(1) | $356,557 | $342,119 | 4.2% | $946,145 | $942,753 | 0.4% |
(1) Adjusted EBITDA is a non-GAAP financial measure. Please see "Non-GAAP Financial Measures" at the end of this press release for a reconciliation of Adjusted EBITDA to net income, the most directly comparable financial measure prepared in accordance with generally accepted accounting principles in the United States ("GAAP").
Business Metrics
| Three Months Ended | Nine Months Ended | |||
|---|---|---|---|---|
| September 30, 2026 | September 30, 2025 | 2026 | 2025 | |
| Patient encounters | ||||
| Emergent transports | 874,239 | 846,679 | 2,557,487 | 2,502,722 |
| Non emergent transports | 203,894 | 205,889 | 611,132 | 635,337 |
| Total ambulance transports | 1,078,133 | 1,052,568 | 3,168,619 | |
| 3,138,059 of which, Ground transports | 1,040,394 | 1,014,764 | 3,060,386 | |
| 3,032,480 of which, Flights | 37,739 | 37,804 | 108,233 | 105,579 |
| Wheelchair transports | 6,457 | 17,363 | 21,140 | 50,078 |
| Nurse Navigation encounters | 32,180 | 21,326 | 89,211 | 59,805 |
| Non-transport | 283,432 | 292,286 | 835,832 | 843,958 |
| Total patient encounters | 1,400,202 | 1,383,543 | 4,114,802 | 4,091,900 |
| Net transport revenue per ambulance transport | $1,426 | $1,384 | $1,386 | $1,332 |
| Other key performance indicators: | ||||
| Emergent air transport requests | 84,126 | 81,854 | 239,916 | 234,628 |
| Air base count | 386 | 383 | 386 | 383 |
| Weather cancellation rate for emergent air transports | 15.7% | 14.8% | 16.1% | 17.0% |
| Same market revenue growth | 6.0% | 9.5% | 5.8% | 12.0% |
Net cash capital expenditures (in thousands)
$
54,699
$
57,082
$
175,110
$
136,013
Cash used in aircraft financing arrangements (in thousands)
$
27,481
$
25,299
$
79,959
$
74,799
Payor mix (as a percentage of net transport revenue):
Medicare
%
%
%
%
Medicaid
%
%
%
%
Commercial insurance and managed care
%
%
%
%
Other third-party payors
%
%
%
%
Self-pay
%
%
%
%
Net transport revenue
%
%
%
%
Full Year 2026 Financial Guidance
GMR is updating the following guidance for the full year 2026:
(in millions)
Range for the year ending
| December 31, 2026 | ||
|---|---|---|
| Low | ||
| High | ||
| Net revenue | $5,900 | $6,050 |
| Adjusted EBITDA(2) | $1,135 | $1,195 |
Cash used for net capital expenditures a
Similar companies
Companies of similar size in SIC 4700 and related industry codes: the same peer list as the financial tables.
- RXO RXO public float $2.6B, Jun 30, 2025
- XPO XPO public float $14.4B, Jun 30, 2025
- Global Business Travel Group GBTG public float $681M, Jun 30, 2025
- GXO Logistics GXO public float $5.5B, Jun 30, 2025
- ModivCare MODVQ